We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RVSN:NASDAQRail Vision Ltd. Analysis

Data as of 2026-06-12 - not real-time

$4.36

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Rail Vision’s stock sits at $4.36, well below its 20‑day (4.97) and 50‑day (6.71) SMA, and even far under the 200‑day SMA of 199.71, indicating a strong bearish trend. The RSI of 21.8 signals oversold conditions, while the MACD shows a bullish histogram (+0.16) despite a negative MACD line, suggesting a potential reversal. The company’s financials are weak: revenue is modest ($1.48 M) with 131% growth, but operating margins are negative (‑4.8%) and there is no profit, leading to a –99% max drawdown and a negative forward P/E (‑2.08). However, the price‑to‑book (0.43) and price‑to‑sales (6.43) ratios are low, and the upside/downside potential is 129%, suggesting the stock may be undervalued.
Recent announcements of a non‑binding MOU with Railserve to expand collaborations and the successful integration of quantum error‑correction technology by its subsidiary add a layer of strategic growth potential. Yet, the market’s “Extreme Greed” sentiment (fear‑greed index 89.82) and the high volatility (≈70%) and beta (2.74) amplify risk, making the near‑term outlook uncertain while the long‑term prospects hinge on the successful rollout of AI‑based railway safety solutions.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical trend (SMA, volume)
  • High volatility and beta
  • Negative operating margins and earnings

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI and low P/B ratio
  • MOU with Railserve expanding market footprint
  • Quantum integration milestone

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Potential 129% upside
  • Robust cash reserve vs. low debt
  • Future AI‑driven railway safety demand

Key Metrics & Analysis

Financial Health

Revenue Growth131.90%
P/E Ratio-2.1
ROE-58.37%
ROA-34.00%
Debt/Equity1.22
P/B Ratio0.4
Op. Cash Flow$-9122000
Free Cash Flow$-5886625
Industry P/E30.6

Technical Analysis

TrendBearish
RSI21.8
Support$4.20
Resistance$6.55
MA 20$4.97
MA 50$6.71
MA 200$199.71
MACDBullish
VolumeDecreasing
Fear & Greed Index89.82

Valuation

Target Price$10.00
Upside/Downside129.36%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.74
Volatility69.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.